Home/Solutions/Medical Device

Medical Device

Cleared does not mean covered.
Know the difference before launch.

FDA clearance and payer coverage are two separate decisions. Polify maps every payer's coverage position for your device category, identifies the evidence gaps standing between you and coverage, and monitors the landscape as it evolves.

Note: Polify focuses on the medical benefit side of coverage. This includes devices and procedures covered under the medical benefit, as well as some drugs covered under the medical benefit. Polify does not monitor pharmaceutical drug coverage, step therapy edits, or formulary policy under the pharmacy benefit.

The coverage problem

FDA clearance and payer coverage are two separate decisions.

A 510(k) clearance or PMA approval establishes that a device is safe and effective. It does not establish that any payer will cover it. Coverage is determined independently by each payer, under their own evidentiary standards, on their own timeline. Many cleared devices reach the market with no coverage policy in place.

Coverage gaps are discovered after the sales infrastructure is built.

By the time a field team is trained and a territory is assigned, the coverage landscape should already be mapped. When it is not, the first calls surface objections that could have been anticipated. Coverage gaps found in the field are expensive to close.

Payer policies for a device category are not in one place.

Commercial payer policies, Medicare Local Coverage Determinations, and Medicaid managed care policies each live in separate systems, use different terminology, and update on different schedules. Assembling a complete picture manually takes weeks and goes stale immediately.

How it works

From device category to coverage strategy.

01

Map the current coverage landscape

Enter your device category or FDA clearance number. Polify maps current coverage positions across commercial payers, Medicare, and Medicaid, with the criteria each payer applies.

02

Identify evidence gaps by payer

Polify compares your evidence package against each payer's published evidentiary standards. Gaps are specific, cited, and actionable.

03

Build the market access strategy

With a complete coverage map and gap analysis in hand, your market access team can prioritize payer outreach, target evidence generation, and sequence the launch.

04

Monitor as the landscape evolves

Coverage policies change after launch. Polify monitors continuously and surfaces changes before they affect the field team or the revenue cycle.

What Polify provides for medical device teams

Coverage intelligence built for market access.

Coverage position mapping

Current coverage positions across commercial payers, Medicare LCDs, and Medicaid managed care for your device category. Which payers cover, which classify as investigational, and what criteria each applies.

Evidence gap analysis

Map the gap between your current evidence package and what each payer requires for coverage. Specific gaps by payer, with citations to the policy language that creates each gap.

Prior authorization requirements

PA requirements by payer and line of business, updated as payers revise their criteria. Know what documentation is required before the first claim is submitted.

Policy version history

Access the full version history of payer policies for your device category. Understand how coverage has evolved, when key changes occurred, and what the trajectory suggests about future policy movement.

Competitive coverage benchmarking

Compare coverage positions for your device against predicate devices and competitive alternatives. Identify where competitors have coverage advantages and what evidence drove those decisions.

Policy change monitoring

Continuous monitoring across all relevant payer policies. Alerts when coverage criteria, PA requirements, or coverage status changes for your device category.

Who uses Polify for device coverage

Built for every team that touches coverage.

Coverage intelligence is not a single team's problem. Market access, regulatory, revenue cycle, and clinical affairs all need current, accurate coverage data. Polify provides a shared source of truth across the organization.

Market access teams preparing for launch
Regulatory and clinical affairs teams
Reimbursement consultants supporting device clients
Revenue cycle teams managing device-related claims
Private equity and venture investors evaluating coverage risk
Health economics and outcomes research teams

What a coverage map includes

Current coverage position for each target payer
Coverage criteria and documentation requirements
Prior authorization requirements by payer and line of business
MAC-level distribution across Medicare jurisdictions
Active review cycles and recent policy updates
Evidence gap analysis by payer
Competitive coverage benchmarking against predicate devices
Policy version history and change timeline

Know where your device stands before the first call.

Polify was built by people who understand how payer coverage decisions are made. The intelligence in the product reflects more than 20 years of payer policy experience.